• Frontage Holdings Corporation appointed Chandra Prakash as senior adviser for clinical services on June 29, 2026.
• Role to guide clinical pharmacology strategy, including study design, human ADME programs, PBPK modeling, DDI risk assessment, submissions support.
• Prakash previously held academic posts at Vanderbilt and the University of Maryland.
• He also held senior scientific leadership roles at Agios Pharmaceuticals, Biogen, Pfizer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Frontage Holdings Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: NE94296) on June 29, 2026, and is solely responsible for the information contained therein.